It has been two years since we started this comparison exercise. The previous year update is here There has been correction in both portfolios since last year, but the quality portfolio has had some significant correction compared to quality at reasonable price one. This has led to the return gap being reduced considerably between the two folios. The high PE folio continues to remain high in most of the cases. We will review it next year and check how these portfolios have performed. For those that are interested in the details, the portfolio valuation and returns as it stands today is given below. Those stocks with an asterix (*) mean that the price has been adjusted for bonus and splits.
Portfolio 1
Portfolio
Annualized Return: 7.6%
Stock
|
Price
|
PE
|
Investment
|
Price
|
PE
|
Value
|
Jubiliant
Foodwords
|
1340
|
76
|
10000
|
833
|
54
|
6216
|
Page
Industries
|
10743
|
68
|
10000
|
13674
|
62
|
12728
|
Symphony
*
|
954
|
62
|
10000
|
1210
|
51
|
12683
|
La
Opala
|
410
|
62
|
10000
|
505
|
44
|
12317
|
Berger
Paints *
|
148
|
53
|
10000
|
200
|
44
|
13514
|
Britannia
Industries
|
1793
|
52
|
10000
|
2941
|
42
|
16403
|
Pidilite
Industries
|
484
|
50
|
10000
|
613
|
37
|
12665
|
Astral
PolyTechnik
|
420
|
46
|
10000
|
397
|
56
|
9452
|
GSK
Consumer Healthcare
|
5807
|
45
|
10000
|
5007
|
32
|
8622
|
Dabur
India
|
239
|
43
|
10000
|
275
|
37
|
11506
|
Portfolio 2
Portfolio Annualized Return: 4.8%
Stock
|
Price
|
PE
|
Investment
|
Price
|
PE
|
Value
|
Munjal Auto Industries
|
113
|
11
|
10000
|
95
|
17
|
8407
|
Zensar Technologies
|
596
|
11
|
10000
|
1023
|
15
|
17164
|
VST Tillers
|
1349
|
13
|
10000
|
1777
|
20
|
13173
|
eClerx Services *
|
897
|
15
|
10000
|
1434
|
16
|
15987
|
Wipro
|
557
|
16
|
10000
|
466
|
13
|
8366
|
Swaraj Engines
|
934
|
16
|
10000
|
1353
|
29
|
14486
|
VST Industries
|
1912
|
17
|
10000
|
2250
|
20
|
11768
|
Kaveri Seed Company
|
782
|
18
|
10000
|
392
|
16
|
5013
|
Suven LifeSciences
|
210
|
18
|
10000
|
175
|
19
|
8333
|
Tech Mahindra *
|
653
|
21
|
10000
|
476
|
15
|
7289
|
No comments:
Post a Comment